Introduction
One of the key biochemical events in apoptosis is the activation of the caspase family of proteases (Alnemri et al, 1996 ; reviewed in Salvesen and Dixit, 1997) . This activation involves a proteolytic cascade, as all caspase family members are initially synthesized as inactive, single polypeptide precursors and require proteolytic processing themselves to generate the two subunits that form the active protease (Salvesen and Dixit, 1997) .
Caspase-3 has been used as the archetypal and most biologically relevant model for caspase activation in part because the activation of caspase-3 has been observed in many cells under a variety of apoptotic treatments (Darmon et al, 1995; Dubrez et al, 1996; Enari et al, 1996; Erhardt and Cooper, 1996; Han et al, 1996b; Martin et al, 1996; Schlegel et al., 1996) . The mature caspase-3 consists of 17 kDa (p17) and 12 kDa (p12) subunits, which are produced from a 32 kDa (p32) precursor (FernandesAlnemri et al, 1994; Nicholson et al, 1995; Tewari et al, 1995a; Liu et al, 1996; Han et al, 1997) . Some aspects of the mechanism by which the caspase-3 precursor is converted into the active enzyme are known and in particular endogenous caspase-3 in membrane-free cytosolic extracts from various cell lines can be activated by the addition of exogenous cytochrome c and dATP (Liu et al, 1996; Li et al, 1997) or exogenous cytochrome c alone (Han et al, 1997) under appropriate in vitro assay conditions. Since caspase precursors are present in the cytosol of cells whereas active cytochrome c is located in the mitochondria, these observations suggested that the efflux of cytochrome c from mitochondria into the cytosol during the apoptotic induction process was a key regulatory event in the activation of caspase-3.
An additional important contributor to apoptotic regulation is the Bcl-2 family of proteins (reviewed in Farrow and Brown, 1996; Yang and Korsmeyer, 1996) . These proteins can be divided into apoptotic suppressors such as Bcl-2, Bcl-x L , and Mcl-1, and apoptosis effectors such as Bax, Bad, Bak, and Bik/Nbk. The apoptotic suppressors are membrane bound, and found predominately in the outer membranes of mitochondria, the endoplasmic reticulum, and the nuclear envelope (Monaghan et al, 1992; Givol et al, 1994; Lithgow et al, 1994) . The membrane association of these proteins suggested that they might regulate certain membrane activities. Indeed, purified Bcl-2 , Bcl-x L (Minn et al, 1997) , or Bax (Antonsson et al, 1997) formed ion channels in membranes. More importantly, the presence of high levels of Bcl-2 protein in mitochondria caused a block in the process of cytochrome c efflux, and, as a consequence, an inhibition of caspase-3 activation and apoptosis (Kluck et al, 1997; Yang et al, 1997) . This strongly suggested that the apoptotic suppressive activity of Bcl-2 and Bcl-x L was due directly to their inhibitory effect on the process of mitochondria cytochrome c efflux during apoptotic induction. Molecular and biochemical studies have demonstrated that apoptotic suppressors and effectors can physically interact with each other, form heterodimers, and antagonize each other's function (Sato et al, 1994) . In particular, Bcl-2 activity is inhibitable by Bad (Yang et al, 1995) and Bax (Oltvai et al, 1993) , and that of Bcl-x L by Bad (Yang et al, 1995) , Bak Farrow et al, 1995; Kiefer et al, 1995) , and Bax (Boise et al, 1993) . Thus, mitochondrial cytochrome c efflux is a critical step in apoptotic induction, and this process appears to be controlled by the interplay of Bcl-2 family members.
We have described the isolation of a stable clonal variant, HCW-2, of the human promyelocytic leukemia cell line, HL-60 (Han et al, 1996a) . In striking contrast to the parental cells, which were very apoptotic sensitive, HCW-2 cells were highly resistant to the apoptotic effects of many treatments (Han et al, 1995; 1996a) . The resistance of HCW-2 cells to diverse apoptotic treatments suggested that it was unlikely that the cells were defective in multiple individual pathways for the transduction of different apoptotic signals, but rather were defective in a common event(s) that was induced by many apoptotic signal transduction pathways. We demonstrate here that HCW-2 cells are defective in the caspase-3 activation process due to a lack of mitochondrial cytochrome c efflux during apoptotic induction. In addition, we discovered the presence of a cytochrome c-efflux inducing factor (CIF) in HL-60 cells, which was activated by staurosporine (STS) treatment and able to induce mitochondrial cytochrome c efflux in an in vitro assay system. CIF activity was not detected in HCW-2 cells. CIF is thus identified as an important regulator of cytochrome c efflux and the lack of CIF in HCW-2 cells results in a severe block in the mitochondrial cytochrome c efflux process and thus the inability of these cells to activate caspase-3 and apoptosis.
Results
The status of caspases in HL-60 and HCW-2 cells during apoptotic induction
The status of caspase-1, caspase-2, and caspase-3 in HL-60 and HCW-2 cell lines during apoptotic induction by STS was investigated. Both cell lines expressed detectable caspase-2 and caspase-3 but not caspase-1 ( Figure 1A) . In untreated cells, caspase-2 and caspase-3 existed, as expected, as inactive precursors in the cytosol. Treatment of HL-60 cells with 5 mM STS for 4 h selectively induced proteolytic activation of caspase-3 as demonstrated by the disappearance of the caspase-3 precursor (p32) and the appearance of the p17 subunit of the mature caspase-3 ( Figure 1A ). In addition, caspase-3 activity was easily detected in the HL-60 cytosol ( Figure 1B ). In contrast, with the same treatment, neither caspase-2 nor caspase-3 were activated in HCW-2 cells ( Figure 1A and B). DAPI staining of HL-60 cells treated with STS for 4 h revealed that almost all of the cells were apoptotic as illustrated by granular bodies of highly condensed DNA in the nuclei (compare Figure 2A and B). DAPI staining of STS-treated HCW-2 cells revealed no signs of apoptosis (compare Figure 2C and D). Thus, the apoptotic-resistant phenotype of HCW-2 cells was associated with a defect(s) in the pathway leading to caspase-3 activation.
In vitro caspase-3 activation using cytosolic extracts from HL-60 and HCW-2 cells
We next attempted to determine the limiting factors for caspase-3 activation in HL-60 and HCW-2 cells using S-100 cytosolic extracts and an in vitro caspase-3 activation assay (Liu et al, 1996; Han et al, 1997; Li et al, 1997) . The addition of cytochrome c to the S-100 cytosolic extract from HL-60 cells induced proteolytic activation of the endogen- Caspase-3 activity in the S-100 extract from untreated (Ctr) and STS-treated (STS) cells. Activity was measured using the CLONTECH ApoAlert TM CPP32 Fluorescent Assay Kit as described in Materials and Methods ous caspase-3 as illustrated by the disappearance of the 32 kDa (p32) precursor of caspase-3 and the appearance of the 17 kDa (p17) subunit of the mature caspase-3 in Western blot analyses (Figure 3) . Thus, the cytosol of HL-60 cells contained sufficient amounts of all factors, with the sole exception of cytochrome c, for caspase-3 activation.
Unexpectedly, caspase-3 processing also occurred with HCW-2 extracts (Figure 3) . In contrast to HL-60 cells, activation of the endogenous caspase-3 in the HCW-2 S-100 cytosolic extract was not only dependent upon exogenous cytochrome c but also required exogenous dATP (Figure 3) . These results strongly suggested that the . The cells were fixed, stained with 100 ng/ml DAPI and then the cells were washed and photographed using a fluorescent microscope apoptotic defect in HCW-2 cells was not in caspase-3 itself, but in an upstream signalling event since extracts derived from HCW-2 cells were permissive for the induction of caspase-3 whereas intact HCW-2 cells were refractory.
Mitochondrial cytochrome c efflux in HCW-2 cells is blocked during apoptotic induction Cytochrome c, which normally resides within the mitochondria, must be extruded into the cytosolic compartment prior to caspase-3 activation (Kluck et al, 1997; Yang et al, 1997) . Correspondingly, we observed that treatment of HL-60 cells with STS induced a time-dependent accumulation of cytochrome c in the cytosol ( Figure 4A ), which preceded activation of caspase-3 ( Figure 4A and B). The accumulation of cytochrome c in the cytosol of STS-treated HL-60 cells correlated well with the loss of mitochondrial cytochrome c ( Figure 4C ). In contrast, treatment of HCW-2 cells with STS resulted in the appearance of very little cytochrome c in the cytosol, which correlated with an insignificant loss of mitochondrial cytochrome c ( Figure 4C ). Thus, the mitochondrial cytochrome c efflux process in HCW-2 cells was severely defective and this provided an explanation for the inability of these cells to activate caspase-3.
Activation of a cytosolic cytochrome c-efflux inducing factor (CIF)
To study the regulation of the mitochondrial cytochrome c efflux process we developed an in vitro assay system (see Materials and Methods). Incubation of purified mitochondria from HL-60 cells with the S-100 cytosolic extract from STStreated (5 mM, 1 h) HL-60 cells rapidly induced complete cytochrome c efflux ( Figure 5A ). Incubation of mitochondria with buffer or the S-100 cytosolic extract from untreated HL-60 cells failed to induce cytochrome c efflux ( Figure 5A ). Thus, treatment of HL-60 cells with STS activated a specific cytosolic factor(s), which we termed`CIF' (cytochrome cefflux inducing factor).
Incubation of the S-100 cytosolic extract at 458C for 60 min completely inactivated CIF activity ( Figure 5B ) whereas the presence of up to 2 mM thio-ATP (S-ATP), a non-hydrolyzable ATP analog, had no effect on CIFinduced mitochondrial cytochrome c efflux ( Figure 5C ). Therefore, CIF activity was highly heat-labile and apparently independent of ATP hydrolysis.
Control Control
Cyt. Cytochrome c efflux during apoptosis induction is believed to be regulated by the Bcl-2 family of proteins (Kluck et al, 1997; Yang et al, 1997) . Therefore, the status of Bcl-2, Bax, Bad, and Bak proteins in HL-60 mitochondria before and after treatment with CIF (i.e, the S-100 from STS-treated HL-60 cells) was determined. CIF-induced cytochrome c efflux from purified HL-60 cell mitochondria did not cause detectable changes in the levels of the mitochondrial-associated Bcl-2, Bad, Bak, and Bax proteins ( Figure 6 ).
HCW-2 cells lack CIF activity
The lack of cytochrome c efflux in HCW-2 cells during apoptosis induction ( Figure 4C ) suggested that either (i) HCW-2 mitochondria were highly resistant to CIF activity or (ii) that HCW-2 cells lacked CIF activity. To experimentally test these hypotheses we performed heterologous cytochrome c efflux assays. When HCW-2 cell mitochondria were incubated with S-100 cytosolic extract from STS-treated HL-60 cells cytochrome c efflux was rapidly induced ( Figure 7A ). In addition, when S-100 cytosolic extract from either untreated or STS-treated HCW-2 cells was incubated with HL-60 cell mitochondria no efflux of cytochrome c was observed ( Figure  7B ). Together, these results strongly suggested that HCW-2 cells lacked CIF activity and that the absence of this activity was directly related to the lack of cytochrome c efflux and consequently to the lack of caspase-3 activation and the apoptotic-resistant phenotype of HCW-2 cells.
dATP levels in the S-100 extracts from HL-60 and HCW-2 cells
Finally, we investigated why activation of caspase-3 in the S-100 extract from HCW-2 cells required not only cytochrome c but also exogenous dATP whereas caspase-3 activation in the S-100 extract from HL-60 cells required only the addition of exogenous cytochrome c (Figure 3 ). The dATP requirement was dose-dependent, and a minimum of 100 mM exogenous dATP was required for a significant amount of the endogenous caspase-3 in the HCW-2 S-100 cytosolic extract to be activated in the presence of cytochrome c ( Figure 8A ). The dATP requirement appeared to be very specific, because no other deoxynucleotides or nucleotides could replace its function ( Figure 8B ). The non-requirement for exogenous dATP in the caspase-3 activation assay using the HL-60 S-100 Purified mitochondria from HL-60 cells were incubated either with basic buffer (basic buffer), S-100 extract from untreated HL-60 cells (Ctr S-100), or the S-100 extract from HL-60 cells that had been treated with 5 mM STS for 1 h (STS S-100) for the indicated times. At the end of each incubation, the reaction mixture were separated into pellet (mitochondria) and supernatant. The cytochrome c distribution in these two fraction was then analyzed by immunoblotting. Note that the STS S-100 (supernatant, 0 min lane) already contained cytochrome c due to STS-induced mitochondrial cytochrome c efflux into the cytosol in HL-60 cells prior to the preparation of the S-100 extract. (B) CIF activity is heat-labile. Freshly prepared STS S-100 from HL-60 cells was left on ice (08C), or incubated at 37, 41, or 458C for 60 min. The samples were centrifuged at 12 5006g for 5 min to remove denatured proteins. The supernatant was used to incubate mitochondria for 15 min at 378C to test the presence of CIF activity. (C) CIF activity is independent of ATP hydrolysis. The STS S-100 extract was incubated without or with 0.5 mM, or 2 mM of thio-ATP (S-ATP) for 10 min at 208C and then CIF activity was determined CIF activity does not alter the amount of mitochondrial-associated Bcl-2, Bad, Bak, and Bax proteins. Mitochondria from HL-60 cells were incubated for 0 or 15 min with the S-100 extract from HL-60 cells that had been treated with 5 mM STS for 1 h. The samples were then separated into the supernatant (S) and mitochondrial pellet (P). The status of cytochrome c, Bad, Bak, Bax, and Bcl-2 were determined by Western blot analyses cytosolic extract (Figure 3 ) suggested either that HL-60 cells already contained a sufficient amount of dATP in the cytosol to meet the requirement for caspase-3 activation or that the reaction was dATP independent. To test these hypotheses, the effect of apyrase, which metabolizes deoxynucleoside or nucleoside di-and triphosphates into deoxynucleoside or nucleoside monophosphates (Lebel et al, 1980; Laliberte et al, 1983) on the process of cytochrome c-dependent activation of the endogenous caspase-3 in the HL-60 S-100 cytosolic extract was investigated. As a control, the effect of 5'-nucleotidase, which converts deoxnucleoside or nucleoside monophosphates into deoxynucleosides or nucleosides, was also investigated. When apyrase, but not 5'-nucleotidase, was added to the S-100 cytosolic extracts from HL-60 cells, subsequent addition of cytochrome c to the assay system no longer induced caspase-3 activation ( Figure 8C ). This result suggested that dATP was also required for the activation of caspase-3 in the HL-60 S-100 cytosolic extract and that the lack of the need to add exogenous dATP to these extracts was probably due to a sufficient endogenous level.
To confirm this hypothesis, we determined the concentration of dATP in the HL-60 and HCW-2 extracts. The dATP concentration in the S-100 extracts from HL-60 and HCW-2 cells was 409.5 mM and 98.3 mM, respectively (Table 1) . Using these values, the concentration of the endogenous dATP in the caspase-3 activation assay was calculated to be 327.6 mM, and 78.6 mM for HL-60 and HCW-2 cells, respectively (Table 1) . These results indicated that, unlike the parental HL-60 cells, HCW-2 cells contained a much lower level of dATP in their cytosol. This low level of dATP in the HCW-2 S-100 extract may be the reason why exogenous dATP was required for the activation of caspase-3 in vitro. Figure 8 The dATP requirement for caspase-3 activation. (A) In the caspase-3 activation assay (Figure 3 ), the HCW-2 cell S-100 extract was supplemented with 0.4 mg of cytochrome c alone or various concentrations of dATP. The 32 kDa precursor of caspase-3 is indicated as p32. p20 indicates an intermediate product derived from p32, which is then converted into the mature p17 subunit during the caspase-3 activation process (Han et al, 1997) . (B) In the caspase-3 activation assay, the HCW-2 cell S-100 extract was supplemented with 0.4 mg cytochrome c and either incubated with an aliquot of buffer alone (Control) or with 1.5 mM of the indicated compound. (C) Inhibition of the cytochrome c-dependent activation of the endogenous caspase-3 in the S-100 extract from HL-60 cells by apyrase. In the caspase-3 activation assay the S-100 extract from HL-60 cells was incubated with buffer (7) or 0.4 mg cytochrome c (+) for 60 min at 378C. Alternatively, the S-100 extract was first incubated with 50 mU 5'-nucleotidase, or 50 mU apyrase for 5 min at 208C. Then, 0.4 mg cytochrome c was added to each sample and the incubation continued at 378C for 60 min. The reaction mixtures were then subjected to a Western blot analysis for caspase-3
Regulation of mitochondrial cytochrome c efflux Z. Han et al cytosol. Therefore, regulation of mitochondrial cytochrome c efflux was the limiting step for caspase-3 activation and thus apoptotic induction in HL-60 cells. Furthermore, we developed a reliable assay for studying how mitochondrial cytochrome c efflux is regulated. Using this assay, we have identified a heatlabile, STS-activatable cytosolic factor (termed CIF) in HL-60 cells, which rapidly induced mitochondrial cytochrome c efflux. Apoptotic-resistant HCW-2 cells failed to activate caspase-3 because there was a severe block in the mitochondrial cytochrome c efflux process, which was associated with a lack of CIF activity. Therefore, the apoptotic phenotypes of HL-60 and HCW-2 cells appeared to be a function of cytochrome c efflux regulation by CIF and the ultimate ability or inability, respectively, to activate caspase-3.
The lack of CIF activity correlates with the apoptotic-resistant phenotype of HCW-2 cells HL-60 cells are extremely sensitive to the apoptotic effects of many different chemical and physical treatments (Martin et al, 1990; Boe et al, 1991; Ishida et al, 1992; Gong et al, 1993; Bertrand et al, 1994; Kiguchi et al, 1994; Han et al, 1995; 1996a) . The HCW-2 cell line was isolated originally as a stable clonal variant of HL-60 by virtue of the cell's ability to survive a long-term treatment with 8-chloro-adenosine 3', 5'-cyclic monophosphate (Han et al, 1996a) . Subsequently, HCW-2 cells were also found to be highly resistant to the apoptotic effect of other chemical and physical treatments including cycloheximide or STS exposure, and X-irradiation (Han et al, 1995; 1996a) . Such a resistance profile indicated that HCW-2 cells were unlikely to be defective in the signal transduction pathways that mediate the apoptotic effect of each individual treatment. Rather, a defect(s) in the centralized apoptotic signal transduction pathway was most likely to be responsible for this phenotype. In particular, caspase-3 activation occurs in many cell lines under a variety of apoptotic conditions (Darmon et al, 1995; Tewari et al, 1995a; Dubrez et al, 1996; Enari et al, 1996; Erhardt and Cooper, 1996; Han et al, 1996b; Martin et al, 1996; Schlegel et al, 1996) . Importantly, it had also been shown that the inhibition of caspase-3 activity in cells could block apoptosis (Darmon et al, 1995; Tewari et al, 1995b; Dubrez et al, 1996; Enari et al, 1996; Martin et al, 1996; Schlegel et al, 1996) . Our results strongly suggest that the apoptotic-resistant phenotype of HCW-2 cells is due to their inability to activate caspase-3 during apoptosis. This is not due to a defect in caspase-3 per se (Figure 3 ) but due to the lack of CIF and the related inability to flux mitochondrial cytochrome c into the cytosol ( Figure 7B ). The in vitro activation of endogenous caspase-3 in the cytosolic extract from HL-60 cells did not require exogenous dATP (Figure 3 ). This was due to the presence of high levels of endogenous dATP in the extract ( Figure  8C and Table 1 ). In contrast, activation of caspase-3 in the S-100 extract from HCW-2 cells was dependent on both exogenous cytochrome c and dATP (Figure 3) . Thus, at first glance, it appeared that the small dATP pool size in the S-100 extract from HCW-2 cells (Table 1 ) correlated well with the cells' in vivo inability to activate caspase-3. However, although small in comparison with HL-60 cells, the actual dATP pool size in HCW-2 cells may not be a limiting factor for caspase-3 activation in vivo. The concentration of endogenous dATP in the caspase-3 activation assay using the HCW-2 S-100 extract was calculated to be approximately 78.6 mM (Table 1) . In a typical assay, when the S-100 extract from HCW-2 cells was used, at least 100 mM of additional exogenous dATP was required for the activation of a significant amount of caspase-3 ( Figure 8A ). This suggested that the presence of approximately 180 mM dATP is required for caspase-3 activation. However, when the S-100 extract was prepared from HCW-2 cells, the ratio of the final lysate volume to the volume of the original wet cell pellet was at least 2 : 1 (see Materials and Methods) . This corresponds to a twofold dilution of the cytosolic components in the S-100 extract. If this dilution factor is taken into consideration, then the actual dATP concentration in the cytosol of intact HCW-2 cells should be at least 160 mM. Accordingly, at this dATP concentration significant caspase-3 activation can probably occur when a sufficient amount of cytochrome c is available ( Figure 8A ). Therefore, the dATP pool size in HCW-2 cells may not be a limiting factor for caspase-3 activation in vivo.
Cytochrome c efflux and CIF
The original finding (Liu et al, 1996) that cytochrome c was required for caspase-3 activation indicated that mitochondrial cytochrome c efflux should play a key role in apoptotic regulation, since biologically active cytochrome c protein is localized in the intermembrane space of mitochondria. Indeed, an early event during apoptotic induction in HL-60 cells is the efflux of mitochondrial cytochrome c into the cytosol, which is followed by caspase-3 activation (Yang et al, 1997) . More interestingly, this process appeared to be regulated by the Bcl-2 family of proteins. Specifically, mitochondria in HL-60 cells that contained an excess amount of Bcl-2 protein due to ectopic over-expression of the gene were blocked in cytochrome c efflux (Yang et al, 1997) . These studies suggested that the ability of apoptotic suppressors such as Bcl-2 and Bcl-x L to block apoptosis was directly due to their ability to block mitochondrial cytochrome c efflux, and thus caspase-3 activation. In this study, we show that CIF, a cytosolic factor, also plays a significant regulatory role for mitochondrial cytochrome c efflux during apoptosis. CIF's salient features are: (i) its activity was not found in cells under normal conditions ( Figure 4C and 5); (ii) it was rapidly activated by STS ( Figure 4C , 5 and 7); (iii) it was very heat labile ( Figure 5B) ; (iv) it did not require ATP hydrolysis ( Figure 5C ); (v) it did not alter the amount of mitochondrial membrane associated Bcl-2 family proteins ( Figure 6) ; and (vi) it was not detected in HCW-2 cell cytosol ( Figure 7B) . Therefore, we envision that treatment of HL-60 cells with STS activates CIF, which then interacts with specific mitochondrial proteins and induces cytochrome c efflux. The consequences are caspase-3 activation and apoptosis (Figure 9 ). This hypothesis suggests that Bcl-2 and related proteins may be downstream targets of CIF. Thus, CIF may inactivate Bcl-2, either by directly binding to it or by modifying the protein in some unknown fashion and this should facilitate the efflux of cytochrome c from the mitochondria. If such a Bcl-2 : CIF interaction does take place it apparently does so without affecting the size, stability or location of mitochondrial Bcl-2 (Figure 6 ). When Bcl-2 is in excess of CIF, mitochondria may be resistant to CIF. This is consistent with the observation that Bcl-2-overexpressing HL-60 cells are blocked in the process of cytochrome c efflux (Yang et al, 1997) . Currently, numerous cell death effector molecules including Bax (Oltvai et al, 1993) , Bad (Yang et al, 1995) , Bcl-x S (Boise et al, 1993) , Bik/Nbk (Boyd et al, 1995; Han et al, 1996) , Bid , and Hrk (Inohara et al, 1997) are known to interact with Bcl-2 and antagonize its activity. Therefore, some of these proteins may fulfill the function of CIF. Since HL-60 cells do not express the bcl-x gene (Han et al, 1996a) , Bcl-x S is an unlikely candidate. In addition, the mitochondria of HL-60 cells contain Bax and Bad proteins under normal (non-induced) conditions and are therefore unlikely to be candidates for CIF (Figure 6 ). The most interesting candidates for CIF could be Bik/Nbk, Bid, and/or Hrk. In particular, it has been demonstrated that overexpression of Bik/Nbk (Boyd et al, 1995; Han et al, 1996) , Bid , or Hrk (Inohara et al, 1997) in cells by itself causes cell death without subjecting the cells to an apoptotic treatment. Since Bik/Nbk, Bid, and Hrk interact with and antagonize the biological function of Bcl-2, it could be speculated that one or more of these proteins may inhibit mitochondrial Bcl-2 activity and directly induce cytochrome c efflux, thus causing caspase-3 activation and apoptosis. We are currently using the in vitro cytochrome c efflux assay to assess whether Bik/Nbk, Bid or Hrk is consistent with being CIF.
Another plausible hypothesis is that CIF and Bcl-2 compete with each other for binding to the same target protein in the membrane of mitochondria. The results of CIF or Bcl-2 binding, however, would have different biological results. Thus, binding of Bcl-2 to the target protein would block, whereas binding of CIF would facilitate, cytochrome c efflux. In this regard, mitochondrial Bax and Bad would be strong candidates for the target protein. This model is also attractive since it would explain why the simple overexpression of Bax (Oltvai et al, 1993) or Bad (Yang et al, 1995) in cells does not result in apoptosis, but is still dependent upon apoptotic induction.
In summary, we have characterized a biochemical pathway which is essential for apoptotic induction triggered by STS in HL-60 cells (Figure 9 ). In addition, we have identified the defect in the apoptotic resistant HCW-2 cell line as a failure to flux cytochrome c. Lastly, and most importantly, we have demonstrated that HL-60 cells possess a cytoplasmic activity, CIF, that appears to be required for cytochrome c efflux. The further characterization of CIF should greatly facilitate our understanding of the apoptotic mechanism.
Materials and Methods

Materials
Fetal bovine serum (FBS), EDTA, phenylmethylsulfonyl fluoride (PMSF), aprotinin, antipain, leupeptin, purified cytochrome c from rat heart, and dATP were purchased from Sigma Chemical, Co (St Louis, MO). Staurosporine (STS) was purchased from Kamiya Biomedical Co. (Seattle, WA). The Complete TM protease inhibitor cocktail tablets were purchased from Boehringer Mannheim Co (Indianapolis, IN). One tablet was dissolved in 50 mL solution to give a 16 concentration of the protease inhibitors. The caspase-3 activity assay reagents (ApoAlert TM CPP32 Fluorescent Assay Kits) were produced by CLONTECH Laboratories, Inc. (Palo Alto, CA). Human caspase-1 antibodies were purchased from Oncogene Sciences, Inc. (Uniondal, NY). Human caspase-2 and caspase-3 antibodies were purchased from Transduction Laboratories, Inc. (Lexington, KY). Monoclonal antibodies against cytochrome c have been described (Jemmerson et al, 1991) . Protein quantitation reagents were purchased from Bio-Rad Laboratories, Inc. (Hercules, CA). ECL Western blot analysis reagents were purchased from Amersham Life Science, Inc. (Arlington Heights, IL).
Cells
HL-60 and HCW-2 cells were cultured in RPMI 1640 medium supplemented with 20% and 10% FBS, respectively. The medium also contained 100 U/ml penicillin and 50 U/ml streptomycin. Cells were incubated at 378C in a humidified incubator with 5% CO 2 .
Mitochondrial cytochrome c ef¯ux and caspase-3 activation during apoptosis
Cells (1610 8 ) were left untreated or treated with 5 mM STS for 0, 1, 2, 3 or 4 h. At the end of each treatment, cells were pelleted by centrifugation and washed in 50 mL of phosphate-buffered saline (PBS) once. The cells were then incubated in 1 ml of the lysis buffer (10 mM HEPES, pH 7.5, 5 mM MgCl 2 , 1 mM DTT, 1 mM PMSF, 50 mg/ml each of leupeptin, aprotinin and antipain) on ice for 10 min. It is anticipated that Bcl-2 antagonizes CIF activity at a site on the outer membrane of mitochondria. The efflux of cytochrome c into the cytosol then activates a proteolytic cascade leading to the activation of caspase-3 (Han et al, 1997; Li et al, 1997) as long as the dATP concentration is sufficient and other appropriate factors are available The cells were broken by five passages through a syringe fitted with a 25-gauge needle. The lysate was divided into two equal parts. To isolate mitochondria, the lysate was mixed with 13.5 ml of lysis buffer containing 0.25 M sucrose. The mixture was centrifuged at 5006g for 10 min at 48C to pellet nuclei. The supernatant was then recentrifuged at 10 0006g for 10 min at 48C, and the pellet was used as the mitochondrial preparation. The other half of the initial lysate was immediately centrifuged at 12 5006g for 5 min at 48C to pellet nuclei and mitochondria. The pellet was discarded and supernatant was then centrifuged at 100 0006g for 30 min at 48C. The clarified supernatant (S-100) was used as the cytosolic extract. Fifty ml aliquots of the S-100 extracts were stored at 7808C for the caspase-3 activity assay. The mitochondrial or cytosolic fractions were lysed in a final volume of 600 ml (10% glycerol, 5% b-mercaptoethanol, and 2% SDS), and heated at 1008C for 5 min. Samples were then electrophoresed in 12% polyacrylamide gels, and blotted onto nitrocellulose filters. Cytochrome c and caspases were detected using ECL Western blot reagents.
In vitro caspase-3 activation assay
Concentrated S-100 cytosolic extract was prepared as described above, except that the ratio of the cell pellet volume to lysis buffer volume was 1 : 1. The extract was adjusted to 10 mg protein/ml plus 5% glycerol and stored in small aliquots at 7808C. To activate caspase-3, 20 ml of the S-100 extract was mixed with 2 ml of cytochrome c (0.2 mg/ml), 1 ml of an EDTA stock solution (187 mM), and 2 ml of dATP stock solutions at various concentrations or 2 ml of H 2 O to replace the dATP. The mixture was then incubated at 378C for 1 h. The reaction was terminated by the addition of 6 ml of 56SDS sample loading buffer and heated at 1008C for 5 min. The samples were then subjected to SDS-polyacrylamide gel electrophoresis and Western blot analyses (Han et al, 1997) . Alternatively, 20 ml of the reaction mixture was used for a caspase-3 activity measurement using the ApoAlert TM CPP32 fluorescent assay (CLONTECH Laboratories, Inc.). The caspase-3 activity was quantitated by fluorescence at 505 nm.
In vitro mitochondrial cytochrome c ef¯ux assay
Concentrated S-100 cytosolic extract was prepared from cells as described above. The extract was adjusted to 10 mg/ml protein plus 50 mM KCl, 5 mM EDTA, and 2.56 of the Complete TM protease inhibitor cocktail, and stored in small aliquots at 7808C. To purify mitochondria, cells were washed in PBS three times. The cell pellet was resuspended in two volumes of a 5 mM MgCl 2 solution, and incubated on ice for 2 min. The cells were lysed by being passed through a 25-gauge needle three times. The lysate was immediately mixed with 25 ml of a 0.88 M sucrose/5 mM MgCl 2 solution. The mixture was centrifuged at 14006g for 10 min at 48C to pellet the nuclei. The supernantant was re-centrifuged at 26 0006g for 10 min at 48C to pellet the mitochondria. The supernatant was discarded and the mitochondrial pellet was resuspended in a 0.25 M sucrose/ 5 mM MgCl 2 solution and incubated on ice for 5 min. During this incubation period, an aliquot of the suspension was diluted into 2 ml of the 0.25 M sucrose solution and the OD 520 absorption of this diluted mitochondria suspension was determined. Following this, the stock mitochondria suspension was adjusted to an OD 520 equivalence of approximately 18. Aliquots of 80 ml of the mitochondrial suspension were pipeted into microcentrifuge tubes and the mitochondria were pelleted at 12 5006g for 1 min at 48C. The supernatant was discarded. The mitochondria were resuspended in 100 ml of washing buffer (10 mM HEPES, pH 7.5, 50 mM KCl, 5 mM EDTA), incubated on ice for 2 min, and centrifuged at 12 5006g for 1 min to pellet mitochondria. The supernatant was removed and the mitochondria were immediately used for experiments. Mitochondria were incubated in 20 ml of basic buffer (10 mM HEPES, pH 7.5, 1 mM DTT, 1 mM PMSF, 50 mg/ml each of antipain, aprotinin, and leupeptin, 5 mM MgCl 2 , 5 mM EDTA, 2.56 of the Complete TM protease inhibitor Cocktail, 50 mM KCl) or the S-100 extract at 378C for various lengths of time. To terminate the incubation, the tubes were centrifuged at 12 5006g for 1 min. The supernatant was mixed with 5 mL of 5X SDS-loading buffer, the pellet was dissolved in 25 ml of 16SDS-loading buffer, and the samples were heated at 1008C for 5 min. A 10-ml aliquot of each sample was subjected to electrophoresis in a 12% polyacrylamide gel and subsequently analyzed by immunoblot analysis for the presence of cytochrome c.
DAPI staining of cells
Cells were washed in PBS once and fixed in 2% paraformadehyde-0.1% Triton X-100 PBS solution for 30 min at 48C. The cells were then washed in PBS three times. Cells were stored at 48C in PBS or spun onto slides in a cytospin centrifuge. Cells were stained in PBS containing 100 ng/ml DAPI for 10 min. The slides were then washed in PBS three times and nuclei staining with DAPI were observed under a fluorescent microscope. Apoptotic cells were identified as those with densely stained granular nuclear bodies.
Quantitative analysis of the dATP content in the S-100 extracts The method originally described by Solter and Handschumacher (1969) for quantitative determination of deoxynucleoside triphosphates in cell extracts was adapted and modified for this study. Briefly, 4 ml of HindIII digested lambda DNA (0.5 mg/ml) was mixed with 5 ml of random hexamer oligonucleotides (100 ng/ml) and 6 ml of H 2 O in 1.5 ml microfuge tubes and incubated at 1008C for 5 min. The tubes were then immediately placed on ice for 5 min and subsequently shifted to room temperature for another 5 min. To determine the dATPdependent incorporation of [a- 32 P]dCTP into DNA, 5 ml of 56 reaction buffer (250 mM Tris-HCl, pH 8.0, 50 mM MgCl 2 , 1 mM dCTP, 1 mM dGTP, 1 mM dTTP) and 1 ml of [a-32 P]dCTP (3000 Ci/mmol, 3.3 mM) were added to the tubes. In addition, 2 ml of H 2 O and/or dATP was added to the mixture to give a final concentration of 0, 5, 10, 25, or 50 mM dATP. To determine the amount of dATP in the cellular S-100 extracts, the dATP was replaced by 2 ml of the S-100 extract with various dilutions. Klenow DNA polymerase solution (2 ml at 2.5 U/ml) was then added to each tube and the mixtures were incubated at 378C for 5 min. The reactions were stopped by the addition of 0.5 ml of icecold 20% trichloroacetic acid (TCA) solution to the tubes. Sonicated salmon sperm DNA (100 ml of 5 mg/ml) was added to each tube as carrier DNA. The contents were mixed, incubated on ice for 60 min and then centrifuged at 12 5006g for 10 min at 48C. The supernatant was discarded and the pellet was extracted with 1 ml of the TCA solution on ice for 60 min. Finally, the tubes were centrifuged at 12 5006g for 10 min at 48C. The TCA solution was removed, the tip of the tube which contained the DNA pellet was cut off, and the radioactivity in the pellet was determined by scintillation counting. A standard curve of a linear relationship between the amount of dATP and [a-32 P]dCTP incorporation (c.p.m.) into DNA was obtained and this and the amount of radioactive incorporation into DNA using the S-100 extract were used to determine the concentration of dATP in the extracts.
